Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II/III of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Healthy Children Aged 5-11

NCT04591405 is registered in ClinicalTrials.gov with Institute of Medical Biology, Chinese Academy of Medical Sciences as lead sponsor.

NCT NCT04591405
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04591405 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II/III of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Healthy Children Aged 5-11
Lead sponsor
Institute of Medical Biology, Chinese Academy of Medical Sciences
Phase
Phase 2/3
Overall status
Unknown status
Start date
October 12, 2020
Completion date
July 1, 2024
Enrollment
11,999 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epidemic parotitis, mumps